BLOG
Patient Information
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
October 22, 2025
No Comments
Abstract Objective: Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has shown rapid antidepressant effects, but small study groups and inadequate control conditions in prior studies have
Updates
Our Latest Articles
Elit sit risus lorem proin eget eu molestie nibh odioa non neque turpis proin viverra velarcu venenatis Elit sit risus lorem proin.
October 22, 2025
No Comments
October 22, 2025
No Comments
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept
October 23, 2025
No Comments
